Top Markets
#1 Pleasing Gold Pleasing Gold +601.59%
#2 Islamic Coin Islamic Coin +154.12%
#3 PulseChain PulseChain +52.83%
#4 BOOK OF MEME BOOK OF MEME +41.48%
#5 DogBull DogBull +36.81%
#6 Neiro Neiro +24.76%
#7 Nockchain Nockchain +22.48%
#8 ORDI ORDI +19.01%
#9 SkyAI SkyAI +16.82%
#10 Monad Monad +16.62%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rank in Stocks #27019
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Share Price
$0.16240909
Last synced: 2025-03-04
Market Cap
$35.68M
Change (1 day)
0.27%
Change (1 year)
0.00%
Country
CN
Trade Dali Pharmaceuticalco.,Ltd (603963)

Category

Healthcare
P/S ratio for Dali Pharmaceuticalco.,Ltd (603963)
P/S ratio as of August 2026 TTM: 2.97
According to Dali Pharmaceuticalco.,Ltd latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.97. At the end of 2022 the company had a P/S ratio of 21.68.
P/S ratio history for Dali Pharmaceuticalco.,Ltd from 2012 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 2.97 -90.20%
2023 30.30 39.75%
2022 21.68 91.44%
2021 11.32 41.15%
2020 8.02 23.66%
2019 6.49 60.68%
2018 4.04 -47.25%
2017 7.66 55.55%
2016 4.92 16.41%
2015 4.23 57.93%
2014 2.68 -12.09%
2013 3.04 -4.22%
2012 3.18 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
7.73 160.20%
IN